« Return to News | Miscellaneous

ICON Taps Ovation for New Lifecycle Sciences Business Group

Monday, June 25, 2007 10:56 AM

Dublin-based ICON Clinical has established a new business unit called its lifecycle sciences group, focusing specifically on outcomes research and economic analysis services. The news was announced during the Drug Information Association (DIA) 43rd Annual Meeting in Atlanta. The group will work with stakeholders across the client organization in area such as clinical development, but also with sales and marketing, medical affairs and strategic development groups—units where most contract research organizations (CROs) have less interaction with.

The core of the group will be Illinois-based Ovation, which ICON acquired in July 2006. The company, now a part of ICON’s clinical research division, conducts prospective pharmacoeconomic and quality-of-life analysis, disease and product registries, and health outcomes research.

Originally dubbed Ovation Healthcare Research, the company was founded in 1990. Ovation’s founder and former president Jeff Trotter, has been promoted to senior vice president of ICON's new lifecycle sciences group.

“This time last year, [Ovation] became pretty much the corner stone of ICON’s late stage business, but one of the things that we’ve done in evolving to this lifecycle sciences group is help everyone recognize that what we do isn’t just in the post approval realm. A lot of what we do starts as early as phase II up to through approval and beyond. That is kind of where the concept of lifecycle sciences came from,” said Trotter.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.